Reversibility Assessment

Reversibility assessment determines whether pharmaceutical adverse effects resolve following drug discontinuation. Reversible effects resolve within expected timeframes. Irreversible effects produce permanent organ damage. Recovery kinetics depend on tissue regeneration capacity. Mechanism understanding guides reversibility prediction.

Clinical monitoring detects irreversible changes. Dose modification may prevent irreversible toxicity. Regulatory submissions address reversibility implications. Patient counselling emphasises monitoring importance. Post-approval surveillance identifies unexpected irreversibility.